AZN - AstraZeneca PLC's (AZN) CEO Pascal Soriot on Q4 2020 Results - Earnings Call Transcript

AstraZeneca PLC (AZN) Q4 2020 Earnings Conference Call February 11, 2021, 06:45 AM ET Company Participants Pascal Soriot - Executive Director and Chief Executive Officer Dave Fredrickson - Executive Vice President, Oncology Business Unit Ruud Dobber - Executive Vice President, Biopharmaceuticals Business Unit Marc Dunoyer - Executive Director and Chief Financial Officer Mene Pangalos - Executive Vice President, Biopharmaceuticals R&D Pam Cheng - Executive Vice President, Operations and IT Leon Wang - Executive Vice President, International and China President Susan Galbraith - Oncology R&D Cristian Massacesi - Senior Vice President, Late-Stage Oncology R&D Jose Baselga - Executive Vice President of Oncology R&D Conference Call Participants Richard Parkes - Exane BNP Michael Leuchten - UBS Luisa Hector - Berenberg Keyur Parekh - Goldman Sachs Andrew Baum - Citi Sachin Jain here - Bank of America Merrill Lynch Timothy Anderson - Wolfe Research Jo Walton - Credit Suisse James Gordon - JPMorgan

For further details see:

AstraZeneca PLC's (AZN) CEO Pascal Soriot on Q4 2020 Results - Earnings Call Transcript